Clinical Trials – Myelofibrosis (MF)

DrugCompanyJAK2 InhibitorClinical Trial ID
(click ID for trial info)
PhaseSite Locations / More Info
Ruxolitinib/INCB050465Incyte CorpNCT02718300
open, recruiting
2Click here for trial info
RuxolitinibIncyteYesNCT01348490
open, recruiting

2
RuxolitinibIncyte CorpYesNCT01317875
open, recruiting
1Click here for trial info
Ruxolitinib and NCT02718300Incyte CorpNCT02718300
open, recruiting
2Click here for more info
PF-04449913PfizerNCT02226172
open, recruiting
2Click here for trial info
PacritinibCTI Biopharma Corp.YesNCT03165734
open, recruiting
2


3

Click here for trial info
Itacitinib
Ruxolitinib
IncyteNCT03144687
open, recruiting
2NCT03144687
PIM447, Ruxolitinib, LEE011NovartisN/ANCT02370706
open, recruiting
2Click here for trial info
Ruxolitinib
Thalidomide
Memorial Sloan Kettering Cancer Center
Incyte Corporation
Celgene
M.D. Anderson Cancer Center
NCT030693262Click here for more trial info
NavitoclaxAbbVieNCT032226092Click here for more trial info
Quantitative MRI for MFSanofiN/ANCT01973881N/A
Stem Cell TransplantCenter for International Blood and Marrow Transplant Research
National Marrow Donor Program
National Institutes of Health (NIH)
National Cancer Institute (NCI)
NCT0293447
open, recruiting
Click here for more trial info
Research Tissue BankMPD-RCN/ANCT00666549
open, recruiting
N/AClick here for trial info
PomalidomideCelgeneNoNCT00946270
not recruiting
2Click here for trial info
RuxolitinibMD-RC, NCI, Incyte Corp, NovartisYesNCT01790295
open, recruiting
2Click here for trial info
DurvalumabCelgene
The Leukemia and Lymphoma Society
National Cancer Institute (NCI)
NCT02871323
active, not recruiting
1Click here for trial info
RuxolitinibIncyte CorpNCT01348490
not recruiting
2Click here for trial info
RuxolitinibIncyte CorpNCT02784496
not recruiting
2Click here for trial info
PRM-151PromediorN/ANCT01981850
open, not recruiting
2Click here for more information
ImetelstatJannsenN/ANCT01731951
not recruiting
2click here for trial info